Lack of concordance in the use and monitoring of intravenous aminoglycosides in UK cystic fibrosis centers

Pediatr Pulmonol. 2002 Feb;33(2):165. doi: 10.1002/ppul.10036.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / adverse effects
  • Cystic Fibrosis / complications
  • Deafness / chemically induced
  • Humans
  • Pseudomonas Infections / drug therapy*
  • Tobramycin / administration & dosage*
  • Tobramycin / adverse effects
  • United Kingdom

Substances

  • Anti-Bacterial Agents
  • Tobramycin